Yi Shen Juan Bi Pill Alleviates Bone Destruction in Inflammatory Arthritis Under Postmenopausal Conditions by Regulating EphrinB2 Signaling

Overview

Journal Front Pharmacol

Date 2022 Oct 17

PMID 36249763

Authors

Huihui Xu

Li Tao

Jinfeng Cao

Peng Zhang

Hui Zeng

Hongyan Zhao

Affiliations

Soon will be listed here.

Abstract

Yi Shen Juan Bi Pill (YSJB) is a traditional Chinese medicine (TCM) formulation that has a therapeutic effect upon rheumatoid arthritis (RA), but how YSJB affects bone destruction in arthritis under postmenopausal conditions is not known. We evaluated the therapeutic role of YSJB in bone destruction in postmenopausal arthritis, We used collagen-induced arthritis (CIA) rats who had been ovariectomized (OVX) as models and explored the possible mechanism from the synovium and bone marrow (BM). Arthritis was generated after ovariectomy or sham surgery for 12 weeks. After 14 days of primary immunization, rats were administered YSJB or estradiol valerate (EV) for 28 days. YSJB could prevent bone destruction in the inflamed joints of rats in the OVX + CIA group. CIA promoted osteoclast differentiation significantly in the synovial membrane according to tartrate resistant acid phosphatase (TRACP) staining, and OVX tended to aggravate the inflammatory reaction of CIA rats according to hematoxylin-and-eosin staining. Immunohistochemistry revealed that the synovium did not have significant changes in erythropoietin-producing hepatocellular interactor (ephrin)B2 or erythropoietin-producing hepatocellular (eph) B4 expression after YSJB treatment, but YSJB treatment reduced nuclear factor of activated T cells (NFATc)1 expression. The BM of rats in the OVX + CIA exhibited remarkable increases in the number of osteoclasts and NFATc1 expression, as well as significantly reduced expression of ephrinB2 and ephB4 compared with the CIA group and sham group. YSJB treatment reduced NFATc1 expression significantly but also increased ephrinB2 expression in the BM markedly. These data suggest that YSJB exhibit a bone-protective effect, it may be a promising therapeutic strategy for alleviating bone destruction in arthritis under postmenopausal conditions, and one of the mechanisms is associated with the modulation of ephrinB2 signaling.

References

Kvien T, Uhlig T, Odegard S, Heiberg M . Epidemiological aspects of rheumatoid arthritis: the sex ratio. Ann N Y Acad Sci. 2006; 1069:212-22. DOI: 10.1196/annals.1351.019. View

Shah L, Elshaikh A, Lee R, Joy Mathew C, Jose M, Cancarevic I . Do Menopause and Aging Affect the Onset and Progression of Rheumatoid Arthritis and Systemic Lupus Erythematosus?. Cureus. 2020; 12(10):e10944. PMC: 7557711. DOI: 10.7759/cureus.10944. View

Xia Y, Fan D, Li X, Lu X, Ye Q, Xi X . Yi Shen Juan Bi Pill Regulates the Bone Immune Microenvironment the JAK2/STAT3 Signaling Pathway . Front Pharmacol. 2021; 12:746786. PMC: 8712765. DOI: 10.3389/fphar.2021.746786. View

Li X, Li M . Estrogen downregulates TAK1 expression in human fibroblast-like synoviocytes and in a rheumatoid arthritis model. Exp Ther Med. 2020; 20(2):1764-1769. PMC: 7388267. DOI: 10.3892/etm.2020.8848. View

Valverde-Franco G, Lussier B, Hum D, Wu J, Hamadjida A, Dancause N . Cartilage-specific deletion of ephrin-B2 in mice results in early developmental defects and an osteoarthritis-like phenotype during aging in vivo. Arthritis Res Ther. 2016; 18:65. PMC: 4791873. DOI: 10.1186/s13075-016-0965-6. View

Krepelka P . Estetrol and the possibilities of its clinical use. Ceska Gynekol. 2021; 86(3):217-221. DOI: 10.48095/cccg2021217. View

van der Woude D, van der Helm-van Mil A . Update on the epidemiology, risk factors, and disease outcomes of rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2018; 32(2):174-187. DOI: 10.1016/j.berh.2018.10.005. View

Pennell L, Galligan C, Fish E . Sex affects immunity. J Autoimmun. 2012; 38(2-3):J282-91. DOI: 10.1016/j.jaut.2011.11.013. View

Zhao H, Li J, He X, Lu C, Xiao C, Niu X . The protective effect of yi shen juan bi pill in arthritic rats with castration-induced kidney deficiency. Evid Based Complement Alternat Med. 2012; 2012:102641. PMC: 3329149. DOI: 10.1155/2012/102641. View

10.

Romanovsky A, Ivanov A, Petersen S . Microsomal prostaglandin E synthase-1, ephrins, and ephrin kinases as suspected therapeutic targets in arthritis: exposed by "criminal profiling". Ann N Y Acad Sci. 2006; 1069:183-94. DOI: 10.1196/annals.1351.016. View

11.

Heidari B, Heidari P . Bone mineral density loss in postmenopausal onset rheumatoid arthritis is not greater than premenopausal onset disease. Caspian J Intern Med. 2014; 5(4):213-8. PMC: 4247484. View

12.

Li T, Wang H, Liu R, Wang X, Huang L, Wu Z . The role of EphB4/ephrinB2 signaling in root repair after orthodontically-induced root resorption. Am J Orthod Dentofacial Orthop. 2021; 159(3):e217-e232. DOI: 10.1016/j.ajodo.2020.07.035. View

13.

Stojanovic A, Veselinovic M, Draginic N, Rankovic M, Andjic M, Bradic J . The Influence of Menopause and Inflammation on Redox Status and Bone Mineral Density in Patients with Rheumatoid Arthritis. Oxid Med Cell Longev. 2021; 2021:9458587. PMC: 7810566. DOI: 10.1155/2021/9458587. View

14.

Zhao C, Irie N, Takada Y, Shimoda K, Miyamoto T, Nishiwaki T . Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metab. 2006; 4(2):111-21. DOI: 10.1016/j.cmet.2006.05.012. View

15.

Sammaritano L . Menopause in patients with autoimmune diseases. Autoimmun Rev. 2011; 11(6-7):A430-6. DOI: 10.1016/j.autrev.2011.11.006. View

16.

Hang X, Zhang Z, Niu R, Wang C, Yao J, Xu Y . Estrogen Protects Articular Cartilage by Downregulating ASIC1a in Rheumatoid Arthritis. J Inflamm Res. 2021; 14:843-858. PMC: 7966409. DOI: 10.2147/JIR.S295222. View

17.

Perera P, Peng C, Xue L, Li Y, Han C . Ex vivo and in vivo effect of Chinese herbal pill Yi Shen Juan Bi (YJB) on experimental arthritis. J Ethnopharmacol. 2010; 134(1):171-5. DOI: 10.1016/j.jep.2010.11.065. View

18.

Matsuo K, Otaki N . Bone cell interactions through Eph/ephrin: bone modeling, remodeling and associated diseases. Cell Adh Migr. 2012; 6(2):148-56. PMC: 3499314. DOI: 10.4161/cam.20888. View

19.

Chakraborty D, Sarkar A, Mann S, Agnihotri P, Saquib M, Malik S . Estrogen-mediated differential protein regulation and signal transduction in rheumatoid arthritis. J Mol Endocrinol. 2022; 69(1):R25-R43. DOI: 10.1530/JME-22-0010. View

20.

Ge Y, Feng K, Liu X, Chen H, Sun Z, Wang C . The Recombinant Protein EphB4-Fc Changes the Ti Particle-Mediated Imbalance of OPG/RANKL via EphrinB2/EphB4 Signaling Pathway and Inhibits the Release of Proinflammatory Factors In Vivo. Oxid Med Cell Longev. 2020; 2020:1404915. PMC: 7294355. DOI: 10.1155/2020/1404915. View